[Epilepsias de origen metabólico en el neonato].

Medicina (B Aires)

Servicio de Neuropediatría, Hospital Universitario Sant Joan de Deu, Barcelona, España. E-mail:

Published: October 2019

Neurometabolic diseases that manifest seizures and epilepsy are a large group of inherited disorders. They can present at any age from the neonatal period to adolescence. The epileptic manifestations can be very varied and, in general, they are epilepsies refractory to antiepileptic drugs. Epileptic phenomenology does not contribute to the diagnosis. The inborn errors of metabolism that respond to the use of cofactors should be known. In acute decompensation, it is essential to provide nutritional, hydroelectrolytic and respiratory support. It is possible that in a few years we can detect the metabolomic profile of these diseases, thus knowing better the diagnosis non-invasively and offering greater therapeutic possibilities for their epilepsy and especially for the underlying disease. We must not forget the transitory metabolic disorders and the electrolyte imbalances within the causes of seizures, especially in the neonatal period, and must be identified and treated early to avoid major damages.

Download full-text PDF

Source

Publication Analysis

Top Keywords

neonatal period
8
[epilepsias origen
4
origen metabólico
4
metabólico neonato]
4
neonato] neurometabolic
4
neurometabolic diseases
4
diseases manifest
4
manifest seizures
4
seizures epilepsy
4
epilepsy large
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!